AusCann Group Holdings will appoint CannPal managing director Layton Mills as CEO of the combined company. The appointment will be made as soon as the transaction is complete. Current CEO Nick Woolf will step down as CEO and remain interim CEO until completion of the handover. AusCann is a pharmaceutical company developing cannabinoid-based medicines.